Company Abbott Laboratories Börse Stuttgart

Equities

ABL

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Börse Stuttgart 03:56:30 2024-07-08 pm EDT 5-day change 1st Jan Change
94.12 EUR +0.11% Intraday chart for Abbott Laboratories -1.85% -5.27%

Business Summary

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows:

- diagnostic systems and instruments (39.1%);

- vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.;

- nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products;

- medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.;

- other (15.9%).

Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).

Sales per Business

USD in Million2022Weight2023Weight Delta
Medical Devices
42.1 %
14,687 33.6 % 16,887 42.1 % +14.98%
Diagnostic Products
24.9 %
16,584 38.0 % 9,988 24.9 % -39.77%
Nutritional Products
20.3 %
7,459 17.1 % 8,154 20.3 % +9.32%
Established Pharmaceutical Products
12.6 %
4,912 11.3 % 5,066 12.6 % +3.14%
Other
0.0 %
11 0.0 % 14 0.0 % +27.27%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
38.5 %
18,142 41.6 % 15,452 38.5 % -14.83%
All Other Countries
35.1 %
14,841 34.0 % 14,084 35.1 % -5.10%
Germany
5.8 %
2,340 5.4 % 2,345 5.8 % +0.21%
China
5.6 %
2,133 4.9 % 2,253 5.6 % +5.63%
India
4.4 %
1,649 3.8 % 1,750 4.4 % +6.12%
Switzerland
4.1 %
1,336 3.1 % 1,638 4.1 % +22.60%
Japan
3.8 %
1,932 4.4 % 1,513 3.8 % -21.69%
Netherlands
2.7 %
-- 1,074 2.7 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Public Communications Contact - -
Corporate Officer/Principal - -
Corporate Officer/Principal - 96-12-31
Corporate Officer/Principal - 96-12-31
General Counsel - 98-12-31
Comptroller/Controller/Auditor 54 17-12-31
General Counsel 58 05-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
Director/Board Member 73 08-10-09
Director/Board Member 64 21-04-22
Director/Board Member 58 23-04-27
Chief Executive Officer 50 14-12-31
Director/Board Member 62 11-12-08
Director/Board Member 57 18-06-07
Director/Board Member 63 19-09-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,989,789,999 1,730,390,898 ( 86.96 %) 250,155,515 ( 12.57 %) 86.96 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.502 %
165,301,921 9.502 % 17 177 M €
BlackRock Advisors LLC
5.934 %
103,236,901 5.934 % 10 727 M €
Capital Research & Management Co. (Global Investors)
4.828 %
83,984,731 4.828 % 8 727 M €
74,738,640 4.296 % 7 766 M €
Capital Research & Management Co. (International Investors)
4.034 %
70,177,564 4.034 % 7 292 M €
Eaton Vance Management
2.070 %
36,011,981 2.070 % 3 742 M €
Geode Capital Management LLC
1.939 %
33,733,715 1.939 % 3 505 M €
Wellington Management Co. LLP
1.624 %
28,258,495 1.624 % 2 936 M €
BlackRock Life Ltd.
1.558 %
27,101,354 1.558 % 2 816 M €
Wells Fargo Bank NA
1.435 %
24,964,871 1.435 % 2 594 M €
NameEquities%Valuation
Bram Bradesco Asset Management S/A DTVM
0.002089 %
43,601 0.002089 % 378 986 €
BB Gestão de Recursos DTVM SA
0.000005 %
100 0.000005 % 869 €

Holdings

NameEquities%Valuation
15,934,048 74.99% 5,280,606,925 $
76,259,451 77.90% 200,850,617 $
17,949,800 51.69% 43,719,789 $
142,136,143 2.98% 9,415,098 $

Company contact information

Abbott Laboratories

100 Abbott Park Road

60064-6400, Abbott Park

+224 667 6100

http://www.abbott.com
address Abbott Laboratories(ABL)

Group companies

NameCategory and Sector
Medical Specialties
Medical Specialties
Medical Specialties
Pharmaceuticals: Major
Abbott Established Products Holdings (Gibraltar) Ltd.
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Medical Specialties
  1. Stock Market
  2. Equities
  3. ABT Stock
  4. ABL Stock
  5. Company Abbott Laboratories